About this trial
This study is conducted to evaluate the safety and performance of robot-assisted microsurgical anastomoses with the MUSA-3 system.
Eligibility criteria
Qualifiers
Patient age ≥ 18 years.
Patients requiring procedures involving micro-anastomosis of small anatomical structures-such as blood vessels, nerves, or lymphatic vessels-in free flap, lymphatic, or peripheral nerve surgery.
Patients who have been selected by the research team at the Clinical Center as appropriate candidates for treatment with MUSA-3 in accordance with the IFU.
Able to give informed consent before participating in the study.
Disqualifiers
Subject participates in a potentially confounding drug or device trial during the course of the study.
Patients that are pregnant or breastfeeding.
≥ISL (International Society of Lymphology) Stage III lymphedema
History of marcaine or indocyanine green allergy
Trial design
Treatments tested in this trial
- Robot-assisted microsurgical anastomoses